Excess mortality in women with pituitary disease: a meta‐analysis
Authors:
- 7 June 2007
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 67 (5) , 693-697
Abstract
Summary: Background Increased mortality has been reported in patients with pituitary disease, with some studies showing higher standard mortality rates (SMR) in women than in men.Objective To assess overall SMR for men and women with benign pituitary disease without excessive ATCH or GH secretion and to investigate associations between SMR and time period of diagnosis.Design From searches in PubMed, Embase and Web of Science databases, and reference lists of major reviews and original articles, we included original studies providing SMR values and 95% confidence intervals (CI) for men and women separately. Thirty articles were studied in detail. Six studies were eligible for the meta‐analysis of sex‐specific mortality, and seven for the analysis of association between SMR and diagnosis period.Results Individual studies (total 5412 patients) reported total SMR values (men and women together) ranging from 1·21 to 3·80. SMR varied from 0·98 to 3·36 in men and from 2·11 to 4·54 in women. Weighted SMR values were significantly higher in women (2·80; CI 2·59–3·02) than in men (2·06; CI 1·94–2 20) (P < 0·0001). SMR was negatively correlated with first year of diagnosis in individual studies (partial correlation analysis controlling for sex, P = 0·017), and approached normal in recent studies in men but not in women.Conclusions In our meta‐analysis of patients with pituitary disease without ACTH or GH excess, SMR was significantly higher in women than in men. SMR reached normal levels in men treated in recent decades, but remained elevated in women.Keywords
This publication has 24 references indexed in Scilit:
- Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary functionPituitary, 2007
- Hormone Therapy and Venous Thromboembolism Among Postmenopausal WomenCirculation, 2007
- Postmenopausal hormone therapy and cardiovascular disease: An overview of main findingsMaturitas, 2006
- Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults – a KIMS database analysisEuropean Journal of Endocrinology, 2006
- Mortality and Vascular Outcomes in Patients Treated for Thyroid DysfunctionThe Journal of Clinical Endocrinology & Metabolism, 2006
- Pituitary Adenomas in Sweden between 1958 and 1991: Incidence, Survival, and MortalityThe Journal of Clinical Endocrinology & Metabolism, 2000
- Increased cerebrovascular mortality in patients with hypopituitarismClinical Endocrinology, 1997
- The effect of hypopituitarism on life expectancyThe Journal of Clinical Endocrinology & Metabolism, 1996
- Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose‐dependent manner and suppresses circadian thyrotrophin levels: studies in GH‐deficient adultsClinical Endocrinology, 1994
- Premature mortality due to cardiovascular disease in hypopituitarismThe Lancet, 1990